 Autism spectrum disorder comprises a broad range of neurodevelopmental disorders that are associated with deficits in social interaction and communication . The tyrosine kinase inhibitor tyrphostin AG126 represents a promising therapeutic agent for several neuroinflammatory disorders . There are currently no treatments available that can improve ASD and we previously showed that AG126 treatment exerts beneficial effects on BTBR T

@highlight The tyrosine kinase inhibitor AG126 attenuates IL 21R IL 21 cytokines in BTBR mice.
@highlight AG126 downregulates pro inflammatory and JAK STAT signaling in BTBR mice.
@highlight AG126 treatment upregulates IL 27
@highlight and Foxp3
@highlight cells.
@highlight AG126 could be a potential therapeutic for the treatment of ASD.
